Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_10386 | 40 | 0.84 | Mlig455_016460, Mlig455_016526, Mlig455_049813 | Neo: - Age: Up-Down-Down |
CHRNA2, CHRNA6 | Mlig455_016460 {REF} {Length: 2441} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=156.6]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=111.5]} {Human: ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=211, Expect=9e-61]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=209, Expect=4e-60]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=201, Expect=5e-56]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=214, Expect=3e-62]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=211, Expect=1e-60]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=216, Expect=6e-63]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=210, Expect=8e-61]} {Smed: dd_Smed_v6_10322_0_1, dd_Smed_v6_10322_0_1, [RH, Score=439, Expect=5e-148]} {RNA1310_41035} {RNA815_43177} Mlig455_016526 {REF} {Length: 2438} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=156.6]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=111.5]} {Human: ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=211, Expect=8e-61]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=209, Expect=4e-60]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=201, Expect=6e-56]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=214, Expect=4e-62]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=211, Expect=1e-60]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=216, Expect=6e-63]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=210, Expect=8e-61]} {Smed: dd_Smed_v6_10322_0_1, dd_Smed_v6_10322_0_1, [RH, Score=439, Expect=4e-148]} {RNA1310_41035} {RNA815_43177} Mlig455_049813 {REF} {Length: 2457} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=156.5]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=109.6]} {Human: ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=209, Expect=5e-60]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=207, Expect=1e-59]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=201, Expect=6e-57]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=201, Expect=3e-57]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=201, Expect=5e-57]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=201, Expect=6e-56]} {Mouse: ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=213, Expect=1e-61]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=212, Expect=1e-61]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=204, Expect=2e-58]; ENSMUSG00000027577, Chrna4, cholinergic receptor, nicotinic, alpha polypeptide 4, [Score=203, Expect=6e-57]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=217, Expect=4e-63]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=209, Expect=1e-60]} {Smed: dd_Smed_v6_10322_0_1, dd_Smed_v6_10322_0_1, [RH, Score=439, Expect=3e-148]} {RNA1310_41035} {RNA815_43177} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -0.845 | 1.178 | 1.00000 | 1.00000 | |
RegionR2 | 0.707 | 1.178 | 0.83624 | 1.00000 | |
RegionR3 | -1.804 | 1.178 | 1.00000 | 1.00000 | |
RegionR4 | -0.115 | 1.178 | 0.99780 | 1.00000 | |
RegionR5 | 0.877 | 1.178 | 0.33505 | 0.68086 | |
RegionR6 | 4.285 | 1.178 | 0.20667 | 0.78180 | |
RegionR7 | -1.823 | 1.178 | 0.99938 | 1.00000 | |
RegionR8 | -1.281 | 1.178 | 0.99781 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -1.064 | 1.178 | 0.99987 | 1.00000 | |
RegenerationR2 | 1.246 | 1.178 | 0.68737 | 0.95177 | |
RegenerationR3 | 1.4 | 1.178 | 0.60209 | 0.90897 | |
RegenerationR4 | 1.357 | 1.178 | 0.49036 | 0.86487 | |
RegenerationR5 | 1.116 | 1.178 | 0.85758 | 1.00000 | |
RegenerationR6 | -3.948 | 1.178 | 0.18348 | 0.51915 | |
RegenerationBL | 2.598 | 1.178 | 0.46688 | 0.83339 | |
RegenerationTP | -0.916 | 1.178 | 0.99965 | 1.00000 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_10386 | 40 | 0.84 | Mlig455_016460, Mlig455_016526, Mlig455_049813 | Neo: - Age: Up-Down-Down |
CHRNA2, CHRNA6 | 5 | 1.000 | - | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_016460 {REF} {Length: 2441} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=156.6]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=111.5]} {Human: ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=211, Expect=9e-61]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=209, Expect=4e-60]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=201, Expect=5e-56]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=214, Expect=3e-62]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=211, Expect=1e-60]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=216, Expect=6e-63]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=210, Expect=8e-61]} {Smed: dd_Smed_v6_10322_0_1, dd_Smed_v6_10322_0_1, [RH, Score=439, Expect=5e-148]} {RNA1310_41035} {RNA815_43177} Mlig455_016526 {REF} {Length: 2438} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=156.6]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=111.5]} {Human: ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=211, Expect=8e-61]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=209, Expect=4e-60]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=201, Expect=6e-56]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=214, Expect=4e-62]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=211, Expect=1e-60]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=216, Expect=6e-63]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=210, Expect=8e-61]} {Smed: dd_Smed_v6_10322_0_1, dd_Smed_v6_10322_0_1, [RH, Score=439, Expect=4e-148]} {RNA1310_41035} {RNA815_43177} Mlig455_049813 {REF} {Length: 2457} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=156.5]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=109.6]} {Human: ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=209, Expect=5e-60]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=207, Expect=1e-59]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=201, Expect=6e-57]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=201, Expect=3e-57]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=201, Expect=5e-57]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=201, Expect=6e-56]} {Mouse: ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=213, Expect=1e-61]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=212, Expect=1e-61]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=204, Expect=2e-58]; ENSMUSG00000027577, Chrna4, cholinergic receptor, nicotinic, alpha polypeptide 4, [Score=203, Expect=6e-57]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=217, Expect=4e-63]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=209, Expect=1e-60]} {Smed: dd_Smed_v6_10322_0_1, dd_Smed_v6_10322_0_1, [RH, Score=439, Expect=3e-148]} {RNA1310_41035} {RNA815_43177} |
2. | MligTC455_24197 | 48 | 1 | Mlig455_062645 | Neo: - Age: - |
KCNH7 | 2.489 | - | - | 0.951 | 0.798 | 0.740 | - | Mlig455_062645 {REF} {Length: 4615} {Pfam: Ion transport protein [PF00520.33, score=125.5]; Cyclic nucleotide-binding domain [PF00027.31, score=51.0]; Ion channel [PF07885.18, score=45.8]} {Human: ENSG00000184611, KCNH7, potassium voltage-gated channel subfamily H member 7, [RH, Score=841, Expect=0.0]; ENSG00000173826, KCNH6, potassium voltage-gated channel subfamily H member 6, [RH, Score=818, Expect=0.0]; ENSG00000055118, KCNH2, potassium voltage-gated channel subfamily H member 2, [RH, Score=805, Expect=0.0]} {Mouse: ENSMUSG00000059742, Kcnh7, potassium voltage-gated channel, subfamily H (eag-related), member 7, [RH, Score=840, Expect=0.0]; ENSMUSG00000001901, Kcnh6, potassium voltage-gated channel, subfamily H (eag-related), member 6, [RH, Score=816, Expect=0.0]; ENSMUSG00000038319, Kcnh2, potassium voltage-gated channel, subfamily H (eag-related), member 2, [RH, Score=805, Expect=0.0]} {Dmel: FBgn0003353, sei, seizure, [RH, Score=780, Expect=0.0]} {Celegans: WBGene00006830, unc-103, Potassium voltage-gated channel unc-103, [RH, Score=764, Expect=0.0]} {Smed: dd_Smed_v6_12621_0_1, dd_Smed_v6_12621_0_1, [RH, Score=841, Expect=0.0]} {RNA1509_16542} {RNA1310_43827} {RNA815_26448} |
3. | MligTC455_35836 | 33 | 0.69 | Mlig455_041101 | Neo: - Age: Up-Down-Up |
KCNMA1 | 1.855 | 0.960 | - | 0.895 | - | - | - | Mlig455_041101 {REF} {Length: 4124} {Pfam: Calcium-activated BK potassium channel alpha subunit [PF03493.20, score=100.6]; Ion transport protein [PF00520.33, score=67.8]; Ion channel [PF07885.18, score=59.4]; Ligand-gated ion channel [PF00060.28, score=25.2]} {Human: ENSG00000156113, KCNMA1, potassium calcium-activated channel subfamily M alpha 1, [Score=919, Expect=0.0]} {Mouse: ENSMUSG00000063142, Kcnma1, potassium large conductance calcium-activated channel, subfamily M, alpha member 1, [Score=911, Expect=0.0]} {Dmel: FBgn0003429, slo, slowpoke, [Score=924, Expect=0.0]} {Celegans: WBGene00004830, slo-1, Calcium-activated potassium channel slo-1, [Score=837, Expect=0.0]} {Smed: dd_Smed_v6_5509_0_1, dd_Smed_v6_5509_0_1, [Score=815, Expect=0.0]} {RNA1509_44704} {RNA1310_3248} {RNA815_7829} |
4. | MligTC455_43783 | 8 | 0.17 | Mlig455_018589 | Neo: - Age: - |
1.842 | - | - | 0.979 | - | 0.863 | - | Mlig455_018589 {REF} {Length: 1005} {Pfam: WSC domain [PF01822.21, score=54.3]} | |
5. | MligTC455_02739 | 17 | 0.36 | Mlig455_050666 | Neo: - Age: - |
1.835 | 0.950 | - | - | - | 0.885 | - | Mlig455_050666 {REF} {Length: 1033} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=25.9]} {RNA1509_42342} {RNA1310_4557} {RNA815_16034.1} | |
6. | MligTC455_23809 | 119 | 2.47 | Mlig455_065200 | Neo: - Age: - |
1.827 | - | - | 0.979 | - | 0.848 | - | Mlig455_065200 {REF} {Length: 2060} {Pfam: Pacifastin inhibitor (LCMII) [PF05375.15, score=33.7]} {RNA1509_46843} {RNA1310_11232} {RNA815_41042} | |
7. | MligTC455_11476 | 26 | 0.54 | Mlig455_035212 | Neo: - Age: - |
1.816 | - | - | 1.000 | - | 0.816 | - | Mlig455_035212 {REF} {Length: 1374} {RNA1310_88897} {RNA815_51066} | |
8. | MligTC455_12438 | 17 | 0.35 | Mlig455_009594 | Neo: - Age: - |
1.803 | - | - | 0.989 | 0.814 | - | - | Mlig455_009594 {REF} {Length: 2044} {RNA1310_39190} {RNA815_29274} | |
9. | MligTC455_13493 | 28 | 0.58 | Mlig455_020299 | Neo: - Age: - |
1.803 | - | - | 0.989 | - | 0.814 | - | Mlig455_020299 {REF} {Length: 568} {RNA1310_11315} {RNA815_53929} | |
10. | MligTC455_40863 | 70 | 1.46 | Mlig455_014267 | Neo: - Age: Up-Down-Down |
PCDH1 | 1.785 | - | - | - | 0.977 | 0.808 | - | Mlig455_014267 {REF} {Length: 5379} {Pfam: Cadherin domain [PF00028.19, score=328.1]; Cadherin-like [PF16184.7, score=31.3]; Cadherin-like [PF08266.14, score=29.2]} {Human: ENSG00000156453, PCDH1, protocadherin 1, [RH, Score=298, Expect=2e-84]} {Mouse: ENSMUSG00000051375, Pcdh1, protocadherin 1, [RH, Score=300, Expect=3e-85]} {Dmel: FBgn0284247, ds, dachsous, [Score=269, Expect=2e-73]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=197, Expect=6e-51]} {Smed: dd_Smed_v6_14117_0_1, dd_Smed_v6_14117_0_1, [Score=404, Expect=8e-123]} {RNA1310_32856} {RNA815_39004} |
11. | MligTC455_48569 | 31 | 0.65 | Mlig455_066874 | Neo: - Age: - |
1.781 | - | - | - | 0.960 | 0.821 | - | Mlig455_066874 {REF} {Length: 1074} {NoTransDecoderORF} {RNA1310_59259} | |
12. | MligTC455_03020 | 77 | 1.61 | Mlig455_031009 | Neo: - Age: - |
PCDH7 | 1.778 | - | - | - | 0.970 | 0.808 | - | Mlig455_031009 {REF} {Length: 4201} {Pfam: Cadherin domain [PF00028.19, score=251.4]} {Human: ENSG00000169851, PCDH7, protocadherin 7, [Score=236, Expect=2e-63]} {Mouse: ENSMUSG00000051375, Pcdh1, protocadherin 1, [Score=263, Expect=2e-72]} {Dmel: FBgn0284247, ds, dachsous, [Score=207, Expect=1e-53]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=172, Expect=3e-43]} {Smed: dd_Smed_v6_17019_0_1, dd_Smed_v6_17019_0_1, [Score=290, Expect=8e-83]} {RNA1509_5672} {RNA1310_47266} {RNA815_2173} |
13. | MligTC455_11823 | 56 | 1.17 | Mlig455_032181, Mlig455_051196 | Neo: - Age: - |
NPAS1 | 1.743 | - | - | - | 0.991 | 0.752 | - | Mlig455_032181 {REF} {Length: 1417} {Pfam: PAS fold [PF08447.14, score=26.5]; PAS fold [PF00989.27, score=24.6]} {Human: ENSG00000130751, NPAS1, neuronal PAS domain protein 1, [Score=184, Expect=4e-52]; ENSG00000151322, NPAS3, neuronal PAS domain protein 3, [Score=182, Expect=7e-50]} {Mouse: ENSMUSG00000001988, Npas1, neuronal PAS domain protein 1, [Score=183, Expect=7e-52]; ENSMUSG00000021010, Npas3, neuronal PAS domain protein 3, [Score=181, Expect=9e-50]} {Dmel: FBgn0262139, trh, trachealess, [Score=192, Expect=1e-53]} {Celegans: WBGene00011327, hlh-34, Helix-loop-helix 34, [Score=97.1, Expect=2e-22]} {Smed: dd_Smed_v6_17731_0_1, dd_Smed_v6_17731_0_1, [Score=160, Expect=2e-43]} {RNA1310_121098} {RNA815_58328} Mlig455_051196 {REF} {Length: 1417} {Pfam: PAS fold [PF08447.14, score=26.5]; PAS fold [PF00989.27, score=24.6]} {Human: ENSG00000130751, NPAS1, neuronal PAS domain protein 1, [Score=184, Expect=4e-52]; ENSG00000151322, NPAS3, neuronal PAS domain protein 3, [Score=182, Expect=7e-50]} {Mouse: ENSMUSG00000001988, Npas1, neuronal PAS domain protein 1, [Score=183, Expect=7e-52]; ENSMUSG00000021010, Npas3, neuronal PAS domain protein 3, [Score=181, Expect=9e-50]} {Dmel: FBgn0262139, trh, trachealess, [Score=192, Expect=1e-53]} {Celegans: WBGene00011327, hlh-34, Helix-loop-helix 34, [Score=97.1, Expect=2e-22]} {Smed: dd_Smed_v6_17731_0_1, dd_Smed_v6_17731_0_1, [Score=160, Expect=2e-43]} {RNA1310_121098} {RNA815_58328} |
14. | MligTC455_43261 | 41 | 0.86 | Mlig455_065982 | Neo: - Age: - |
1.738 | - | - | - | 0.778 | 0.960 | - | Mlig455_065982 {REF} {Length: 581} {RNA1509_55651} {RNA1310_59019} {RNA815_42240} | |
15. | MligTC455_40830 | 347 | 7.23 | Mlig455_016648 | Neo: - Age: - Region-enriched R2: 2.647/0.00743 |
AL139142.2 | 1.733 | - | - | - | 0.967 | 0.766 | - | Mlig455_016648 {REF} {Length: 2698} {TRANSSPLICED} {Pfam: Ankyrin repeats (many copies) [PF13637.8, score=42.1]; Ankyrin repeats (3 copies) [PF12796.9, score=37.6]; Ankyrin repeats (many copies) [PF13857.8, score=28.5]; Ankyrin repeat [PF00023.32, score=28.4]; Ankyrin repeat [PF13606.8, score=26.3]} {Human: ENSG00000285777, AL139142.2, ankyrin repeat domain 45, [RH, Score=103, Expect=2e-26]; ENSG00000183831, ANKRD45, ankyrin repeat domain 45, [RH, Score=103, Expect=2e-26]} {Mouse: ENSMUSG00000044835, Ankrd45, ankyrin repeat domain 45, [RH, Score=103, Expect=2e-26]} {Dmel: FBgn0033785, Sans, Scaffold protein containing ankyrin repeats and SAM domain, [Score=47.4, Expect=5e-06]} {Celegans: WBGene00003931, pat-4, Integrin-linked protein kinase homolog pat-4, [Score=47.0, Expect=5e-06]} {Smed: dd_Smed_v6_10212_0_1, dd_Smed_v6_10212_0_1, [RH, Score=124, Expect=3e-35]} {RNA1509_28742} {RNA1310_27748.2} {RNA815_10838} |
16. | MligTC455_39857 | 27 | 0.55 | Mlig455_037127 | Neo: - Age: Down-Down-Down |
NECAB1 | 1.725 | - | - | - | 0.951 | 0.774 | - | Mlig455_037127 {REF} {Length: 1710} {Pfam: EF-hand domain [PF13405.8, score=34.9]; EF hand [PF00036.34, score=33.1]; EF-hand domain pair [PF13499.8, score=27.6]; EF-hand domain pair [PF13833.8, score=27.3]; Antibiotic biosynthesis monooxygenase [PF03992.18, score=25.2]; EF hand [PF13202.8, score=23.2]} {Human: ENSG00000123119, NECAB1, N-terminal EF-hand calcium binding protein 1, [Score=186, Expect=7e-55]} {Mouse: ENSMUSG00000040536, Necab1, N-terminal EF-hand calcium binding protein 1, [Score=180, Expect=7e-53]} {RNA1310_5770} {RNA815_27367} |
17. | MligTC455_13866 | 60 | 1.26 | Mlig455_059198 | Neo: - Age: - |
1.663 | - | - | - | 0.713 | 0.950 | - | Mlig455_059198 {REF} {Length: 561} {NoTransDecoderORF} {RNA1310_89423} {RNA815_50610} | |
18. | MligTC455_00524 | 6 | 0.12 | Mlig455_035116 | Neo: - Age: - |
1 | - | - | 1.000 | - | - | - | Mlig455_035116 {REF} {Length: 886} {NoTransDecoderORF} | |
19. | MligTC455_39681 | 136 | 2.83 | Mlig455_045908, Mlig455_045958, Mlig455_063327 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-0.624 Region-enriched R2: 4.082/0.00717 |
CASP1, CASP7 | 1 | - | - | 1.000 | - | - | - | Mlig455_045908 {REF} {Length: 1556} {NoTransDecoderORF} {RNA1310_115705} {RNA815_46116} Mlig455_045958 {REF} {Length: 1362} {Pfam: Caspase domain [PF00656.24, score=68.0]} {Human: ENSG00000165806, CASP7, caspase 7, [Score=57.8, Expect=3e-09]} {Mouse: ENSMUSG00000025076, Casp7, caspase 7, [Score=58.9, Expect=1e-09]} {Dmel: FBgn0019972, Drice, Death related ICE-like caspase, [Score=53.1, Expect=6e-08]} {Smed: dd_Smed_v6_1167_0_1, dd_Smed_v6_1167_0_1, [Score=49.7, Expect=4e-07]} {RNA1310_50397} {RNA815_46116} Mlig455_063327 {REF} {Length: 3941} {Pfam: Caspase domain [PF00656.24, score=81.3]} {Human: ENSG00000137752, CASP1, caspase 1, [Score=79.7, Expect=1e-15]} {Mouse: ENSMUSG00000025888, Casp1, caspase 1, [Score=82.8, Expect=1e-16]} {Dmel: FBgn0019972, Drice, Death related ICE-like caspase, [Score=63.2, Expect=2e-10]} {Celegans: WBGene00000417, ced-3, Cell death protein 3 Cell death protein 3 subunit 1 Cell death protein 3 subunit 2, [Score=75.9, Expect=6e-15]} {Smed: dd_Smed_v6_1167_0_1, dd_Smed_v6_1167_0_1, [Score=73.9, Expect=1e-14]} {RNA1509_50041} {RNA1310_2539.1} {RNA815_252.1} |
20. | MligTC455_18814 | 44 | 0.91 | Mlig455_001664 | Neo: - Age: Up-Down-Up |
0.997 | 0.997 | - | - | - | - | - | Mlig455_001664 {REF} {Length: 1673} {Smed: dd_Smed_v6_18585_0_1, dd_Smed_v6_18585_0_1, [Score=100, Expect=1e-23]} {RNA1310_49005} {RNA815_48672} | |
21. | MligTC455_05874 | 5 | 0.11 | Mlig455_049976 | Neo: - Age: - |
0.996 | - | - | 0.996 | - | - | - | Mlig455_049976 {REF} {Length: 389} {TRANSSPLICED} {NoTransDecoderORF} {RNA1310_109621} | |
22. | MligTC455_07273 | 29 | 0.6 | Mlig455_055580, Mlig455_055588 | Neo: - Age: - |
RHAG, RHCG | 0.993 | - | - | - | - | 0.993 | - | Mlig455_055580 {REF} {Length: 2536} {Pfam: Ammonium Transporter Family [PF00909.23, score=189.9]} {Human: ENSG00000112077, RHAG, Rh associated glycoprotein, [Score=332, Expect=6e-110]} {Mouse: ENSMUSG00000023926, Rhag, Rhesus blood group-associated A glycoprotein, [Score=336, Expect=4e-111]} {Dmel: FBgn0028699, Rh50, [Score=339, Expect=3e-112]} {Celegans: WBGene00004358, rhr-1, RH (Rhesus) antigen Related, [Score=331, Expect=4e-109]} {Smed: dd_Smed_v6_1882_0_2, dd_Smed_v6_1882_0_2, [Score=341, Expect=3e-113]} {RNA1509_38665} {RNA1310_3224.1} {RNA815_9166} Mlig455_055588 {REF} {Length: 1962} {Pfam: Ammonium Transporter Family [PF00909.23, score=172.2]} {Human: ENSG00000140519, RHCG, Rh family C glycoprotein, [Score=234, Expect=2e-72]; ENSG00000112077, RHAG, Rh associated glycoprotein, [Score=231, Expect=3e-72]; ENSG00000132677, RHBG, Rh family B glycoprotein (gene/pseudogene), [Score=224, Expect=9e-69]} {Mouse: ENSMUSG00000023926, Rhag, Rhesus blood group-associated A glycoprotein, [Score=231, Expect=4e-72]} {Dmel: FBgn0028699, Rh50, [Score=267, Expect=8e-86]} {Celegans: WBGene00004358, rhr-1, RH (Rhesus) antigen Related, [Score=250, Expect=4e-79]} {Smed: dd_Smed_v6_1882_0_2, dd_Smed_v6_1882_0_2, [Score=266, Expect=3e-85]} {RNA1509_38665} {RNA1310_3224.1} {RNA815_9166} |
23. | MligTC455_12355 | 27 | 0.56 | Mlig455_024618 | Neo: - Age: - |
CHRNA3 | 0.989 | - | - | 0.989 | - | - | - | Mlig455_024618 {REF} {Length: 2865} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=270.1]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=246.9]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [RH, Score=432, Expect=7e-146]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [RH, Score=432, Expect=5e-146]; ENSG00000117971, CHRNB4, cholinergic receptor nicotinic beta 4 subunit, [RH, Score=419, Expect=1e-140]} {Mouse: ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [RH, Score=427, Expect=6e-144]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [RH, Score=426, Expect=2e-143]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [RH, Score=418, Expect=1e-140]; ENSMUSG00000035200, Chrnb4, cholinergic receptor, nicotinic, beta polypeptide 4, [RH, Score=406, Expect=4e-136]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [RH, Score=524, Expect=0.0]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=459, Expect=4e-157]} {Smed: dd_Smed_v6_14630_0_1, dd_Smed_v6_14630_0_1, [RH, Score=521, Expect=6e-180]} {RNA1509_36802} {RNA1310_50512} {RNA815_3014.1} |
24. | MligTC455_15134 | 15 | 0.31 | Mlig455_000804 | Neo: - Age: - |
CNGA3 | 0.989 | - | - | 0.989 | - | - | - | Mlig455_000804 {REF} {Length: 2294} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=62.8]; Ion transport protein [PF00520.33, score=39.4]} {Human: ENSG00000144191, CNGA3, cyclic nucleotide gated channel alpha 3, [Score=351, Expect=2e-113]; ENSG00000198515, CNGA1, cyclic nucleotide gated channel alpha 1, [Score=344, Expect=2e-110]; ENSG00000183862, CNGA2, cyclic nucleotide gated channel alpha 2, [Score=340, Expect=2e-109]} {Mouse: ENSMUSG00000026114, Cnga3, cyclic nucleotide gated channel alpha 3, [Score=352, Expect=9e-115]; ENSMUSG00000067220, Cnga1, cyclic nucleotide gated channel alpha 1, [Score=342, Expect=7e-110]; ENSMUSG00000005864, Cnga2, cyclic nucleotide gated channel alpha 2, [Score=338, Expect=9e-109]} {Dmel: FBgn0259145, CG42260, [Score=463, Expect=1e-153]} {Celegans: WBGene00006526, tax-4, Cyclic nucleotide-gated cation channel, [Score=281, Expect=1e-86]} {Smed: dd_Smed_v6_22398_0_1, dd_Smed_v6_22398_0_1, [Score=343, Expect=2e-111]} {RNA1310_120793} {RNA815_25814} |
25. | MligTC455_15160 | 11 | 0.23 | Mlig455_024917 | Neo: - Age: - |
0.989 | - | - | 0.989 | - | - | - | Mlig455_024917 {REF} {Length: 773} {TRANSSPLICED} {RNA1310_98042} | |
26. | MligTC455_18788 | 27 | 0.57 | Mlig455_040989, Mlig455_040991 | Neo: - Age: - |
0.989 | - | - | 0.989 | - | - | - | Mlig455_040989 {REF} {Length: 1277} {RNA1509_56938} {RNA1310_39299} {RNA815_53904} Mlig455_040991 {REF} {Length: 1852} {RNA1509_56938} {RNA1310_34736} {RNA815_16785.1} |
|
27. | MligTC455_36252 | 20 | 0.42 | Mlig455_050668 | Neo: - Age: - |
PRKAR2B | 0.989 | - | - | 0.989 | - | - | - | Mlig455_050668 {REF} {Length: 1234} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=45.2]} {Human: ENSG00000284096, PRKAR2B, protein kinase cAMP-dependent type II regulatory subunit beta, [Score=93.2, Expect=9e-21]; ENSG00000005249, PRKAR2B, protein kinase cAMP-dependent type II regulatory subunit beta, [Score=93.2, Expect=9e-21]} {Mouse: ENSMUSG00000002997, Prkar2b, protein kinase, cAMP dependent regulatory, type II beta, [Score=93.2, Expect=7e-21]} {Dmel: FBgn0022382, Pka-R2, Protein kinase, cAMP-dependent, regulatory subunit type 2, [Score=96.3, Expect=3e-22]} {Smed: dd_Smed_v6_1362_0_1, dd_Smed_v6_1362_0_1, [Score=87.8, Expect=2e-19]} |
28. | MligTC455_54226 | 52 | 1.09 | Mlig455_037435, Mlig455_037458 | Neo: - Age: - |
NETO2 | 0.989 | - | - | 0.989 | - | - | - | Mlig455_037435 {REF} {Length: 2663} {Pfam: CUB domain [PF00431.22, score=52.2]; Low-density lipoprotein receptor domain class A [PF00057.20, score=31.7]} {Human: ENSG00000171208, NETO2, neuropilin and tolloid like 2, [Score=96.3, Expect=3e-20]} {Mouse: ENSMUSG00000036902, Neto2, neuropilin (NRP) and tolloid (TLL)-like 2, [Score=97.8, Expect=6e-21]} {Dmel: FBgn0265416, Neto, Neuropilin and tolloid-like, [Score=87.8, Expect=1e-17]} {Celegans: WBGene00019360, neto-1, NETO (NEuropilin and TOlloid-like) homolog, [Score=77.4, Expect=4e-15]} {Smed: dd_Smed_v6_8579_0_1, dd_Smed_v6_8579_0_1, [Score=87.0, Expect=1e-17]} {RNA1310_38111} Mlig455_037458 {REF} {Length: 2349} {Pfam: CUB domain [PF00431.22, score=52.1]; Low-density lipoprotein receptor domain class A [PF00057.20, score=31.7]} {Human: ENSG00000171208, NETO2, neuropilin and tolloid like 2, [RH, Score=144, Expect=9e-37]} {Mouse: ENSMUSG00000036902, Neto2, neuropilin (NRP) and tolloid (TLL)-like 2, [RH, Score=146, Expect=1e-37]} {Dmel: FBgn0265416, Neto, Neuropilin and tolloid-like, [Score=117, Expect=2e-27]} {Celegans: WBGene00019360, neto-1, NETO (NEuropilin and TOlloid-like) homolog, [Score=105, Expect=1e-24]} {Smed: dd_Smed_v6_8579_0_1, dd_Smed_v6_8579_0_1, [Score=115, Expect=6e-27]} {RNA1310_38111} |
29. | MligTC455_01196 | 7 | 0.15 | Mlig455_005481 | Neo: - Age: - |
0.983 | - | - | - | - | 0.983 | - | Mlig455_005481 {REF} {Length: 664} {RNA1310_91193} | |
30. | MligTC455_07472 | 9 | 0.19 | Mlig455_000954 | Neo: - Age: - |
0.983 | - | - | - | - | 0.983 | - | Mlig455_000954 {REF} {Length: 308} {NoTransDecoderORF} {RNA1509_43648} {RNA1310_19559.1} {RNA815_8352} | |
31. | MligTC455_48019 | 15 | 0.32 | Mlig455_031400 | Neo: - Age: - |
0.982 | - | - | - | - | 0.982 | - | Mlig455_031400 {REF} {Length: 893} {NoTransDecoderORF} {RNA1310_54309} | |
32. | MligTC455_14351 | 20 | 0.42 | Mlig455_033296 | Neo: - Age: - |
0.981 | - | - | - | 0.981 | - | - | Mlig455_033296 {REF} {Length: 904} {NoTransDecoderORF} {RNA1310_77166} {RNA815_51589} | |
33. | MligTC455_10895 | 168 | 3.49 | Mlig455_026819 | Neo: - Age: Down-Down-Down Region-enriched R3: 2.926/0.02755 |
0.98 | - | - | - | - | 0.980 | - | Mlig455_026819 {REF} {Length: 789} {NoTransDecoderORF} {RNA1310_51062} {RNA815_26657} | |
34. | MligTC455_45063 | 105 | 2.19 | Mlig455_045829, Mlig455_045845, Mlig455_045862 | Neo: - Age: - |
0.98 | - | - | - | 0.980 | - | - | Mlig455_045829 {REF} {Length: 4186} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=185.3]} {Celegans: WBGene00016064, acd-1, [Score=70.9, Expect=1e-12]} {Smed: dd_Smed_v6_19599_0_1, dd_Smed_v6_19599_0_1, [Score=120, Expect=1e-28]} {RNA1509_43949} {RNA1310_15301.1} {RNA815_26865} Mlig455_045845 {REF} {Length: 3433} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=149.9]} {Celegans: WBGene00003174, mec-10, Degenerin mec-10, [Score=61.2, Expect=1e-09]} {Smed: dd_Smed_v6_23771_0_1, dd_Smed_v6_23771_0_1, [Score=101, Expect=1e-22]} {RNA1509_43949} {RNA1310_15301.1} {RNA815_26865} Mlig455_045862 {REF} {Length: 3524} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=185.3]} {Celegans: WBGene00016064, acd-1, [Score=70.9, Expect=1e-12]} {Smed: dd_Smed_v6_19599_0_1, dd_Smed_v6_19599_0_1, [Score=120, Expect=1e-28]} {RNA1509_43949} {RNA1310_15301.1, RNA1509_43949} {RNA1509_43949, RNA815_26865} |
|
35. | MligTC455_03653 | 10 | 0.21 | Mlig455_041202, Mlig455_041205, Mlig455_070103 | Neo: - |
0.979 | - | - | - | - | 0.979 | - | Mlig455_041202 {REF} {Length: 1305} {Pfam: Phage integrase family [PF00589.24, score=29.0]} {RNA1509_54878} {RNA1310_10638.2} {RNA815_26061} Mlig455_041205 {REF} {Length: 1116} {Pfam: Phage integrase family [PF00589.24, score=30.0]} {RNA1509_54878} {RNA1310_10638.2} {RNA815_26061} Mlig455_070103 {REF} {Length: 479} {Pfam: Phage integrase family [PF00589.24, score=31.2]} {RNA1509_54878} {RNA1310_55248} {RNA815_26061} |
|
36. | MligTC455_19148 | 151 | 3.15 | Mlig455_041025 | Neo: - |
DUT | 0.979 | - | - | - | - | 0.979 | - | Mlig455_041025 {REF} {Length: 736} {TRANSSPLICED} {Pfam: dUTPase [PF00692.21, score=108.5]} {Human: ENSG00000128951, DUT, deoxyuridine triphosphatase, [Score=101, Expect=2e-27]} {Mouse: ENSMUSG00000027203, Dut, deoxyuridine triphosphatase, [Score=99.4, Expect=2e-26]} {Dmel: FBgn0250837, dUTPase, Deoxyuridine triphosphatase, [Score=107, Expect=9e-30]} {Celegans: WBGene00010609, dut-1, DeoxyUTPase; Deoxyuridinetriphosphatase, [Score=105, Expect=5e-27]} {Smed: dd_Smed_v6_2921_0_1, dd_Smed_v6_2921_0_1, [Score=105, Expect=1e-29]} {RNA1509_31148} {RNA1310_12927} {RNA815_27386} |
37. | MligTC455_15539 | 17 | 0.35 | Mlig455_024133, Mlig455_055857 | Neo: - Age: - |
CHRNB3 | 0.978 | - | - | - | - | 0.978 | - | Mlig455_024133 {REF} {Length: 1621} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=224.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=166.0]} {Human: ENSG00000147432, CHRNB3, cholinergic receptor nicotinic beta 3 subunit, [Score=325, Expect=2e-106]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=316, Expect=3e-102]} {Mouse: ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=322, Expect=2e-105]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=317, Expect=1e-102]} {Dmel: FBgn0032151, nAChRalpha6, nicotinic Acetylcholine Receptor alpha6, [Score=322, Expect=6e-105]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [RH, Score=296, Expect=2e-95]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [RH, Score=522, Expect=0.0]} {RNA1310_50174} {RNA815_45521} Mlig455_055857 {REF} {Length: 1876} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=168.5]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=165.9]} {Human: ENSG00000147432, CHRNB3, cholinergic receptor nicotinic beta 3 subunit, [Score=282, Expect=2e-90]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=278, Expect=3e-89]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=276, Expect=2e-87]; ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=275, Expect=3e-87]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=269, Expect=5e-85]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=269, Expect=5e-85]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=269, Expect=5e-85]} {Mouse: ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=289, Expect=1e-93]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=276, Expect=9e-88]} {Dmel: FBgn0032151, nAChRalpha6, nicotinic Acetylcholine Receptor alpha6, [Score=282, Expect=2e-90]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=267, Expect=7e-85]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=470, Expect=1e-163]} {RNA1509_33753} {RNA1310_50174} {RNA815_45521} |
38. | MligTC455_41475 | 43 | 0.89 | Mlig455_021663, Mlig455_021712 | Neo: - Age: - |
0.977 | - | - | 0.977 | - | - | - | Mlig455_021663 {REF} {Length: 486} {NoTransDecoderORF} {RNA1310_96898} Mlig455_021712 {REF} {Length: 812} {NoTransDecoderORF} {RNA1310_96898} |
|
39. | MligTC455_49949 | 46 | 0.95 | Mlig455_069056 | Neo: - Age: - |
ASIC1 | 0.977 | - | - | 0.977 | - | - | - | Mlig455_069056 {REF} {Length: 2381} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=204.6]} {Human: ENSG00000110881, ASIC1, acid sensing ion channel subunit 1, [Score=58.5, Expect=3e-08]} {Mouse: ENSMUSG00000023017, Asic1, acid-sensing (proton-gated) ion channel 1, [Score=58.2, Expect=2e-08]; ENSMUSG00000028008, Asic5, acid-sensing (proton-gated) ion channel family member 5, [Score=57.4, Expect=4e-08]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [Score=76.6, Expect=2e-14]} {Smed: dd_Smed_v6_12037_0_1, dd_Smed_v6_12037_0_1, [Score=94.4, Expect=4e-20]} {RNA1509_44792} {RNA1310_8631} {RNA815_5782} |
40. | MligTC455_21941 | 57 | 1.2 | Mlig455_005337, Mlig455_008287, Mlig455_042435, Mlig455_042486 | Neo: - Age: Down-Up-Down |
0.976 | - | - | - | - | 0.976 | - | Mlig455_005337 {REF} {Length: 1085} {RNA1310_43853} {RNA815_33228} Mlig455_008287 {REF} {Length: 716} {Pfam: Phage integrase family [PF00589.24, score=27.0]} {RNA1310_43853} {RNA815_33228} Mlig455_042435 {REF} {Length: 1075} {Pfam: Phage integrase family [PF00589.24, score=24.5]} {RNA1310_28668} {RNA815_33228} Mlig455_042486 {REF} {Length: 1073} {Pfam: Phage integrase family [PF00589.24, score=24.5]} {RNA1509_29315} {RNA1310_28668} {RNA815_33228} |
|
41. | MligTC455_42207 | 33 | 0.68 | Mlig455_043369 | Neo: - Age: logFC(26M/2M)=-0.892 |
ARX | 0.975 | - | - | - | 0.975 | - | - | Mlig455_043369 {REF} {Length: 2592} {Pfam: Homeodomain [PF00046.31, score=81.7]} {Human: ENSG00000004848, ARX, aristaless related homeobox, [Score=117, Expect=5e-28]} {Mouse: ENSMUSG00000024518, Rax, retina and anterior neural fold homeobox, [RH, Score=112, Expect=1e-27]} {Dmel: FBgn0008636, hbn, homeobrain, [RH, Score=142, Expect=5e-38]} {Celegans: WBGene00044330, alr-1, AristaLess (Drosophila homeodomain) Related, [RH, Score=122, Expect=3e-31]} {Smed: dd_Smed_v6_36829_0_1, dd_Smed_v6_36829_0_1, [RH, Score=105, Expect=7e-26]} {RNA1310_66015} |
42. | MligTC455_52148 | 59 | 1.22 | Mlig455_009705 | Neo: - |
OTOP2 | 0.975 | - | - | - | 0.975 | - | - | Mlig455_009705 {REF} {Length: 4514} {Pfam: Otopetrin [PF03189.15, score=268.1]} {Human: ENSG00000183034, OTOP2, otopetrin 2, [RH, Score=81.6, Expect=3e-15]} {Mouse: ENSMUSG00000050201, Otop2, otopetrin 2, [RH, Score=94.4, Expect=2e-19]} {Dmel: FBgn0259150, CG42265, [RH, Score=253, Expect=2e-69]} {Celegans: WBGene00010403, otpl-8, OToPetrin-Like, [Score=150, Expect=7e-38]} {Smed: dd_Smed_v6_15458_0_1, dd_Smed_v6_15458_0_1, [RH, Score=369, Expect=1e-112]} {RNA1509_36589} {RNA1310_11799, RNA1509_36589} {RNA1509_36589, RNA815_54951} |
43. | MligTC455_07965 | 20 | 0.41 | Mlig455_022984 | Neo: - Age: - |
0.973 | - | - | - | - | 0.973 | - | Mlig455_022984 {REF} {Length: 2834} {NoTransDecoderORF} {RNA1509_35506} {RNA1310_48890} {RNA815_24918} | |
44. | MligTC455_13774 | 4 | 0.09 | Mlig455_016147 | Neo: - Age: - |
0.973 | - | - | - | - | 0.973 | - | Mlig455_016147 {REF} {Length: 680} {NoTransDecoderORF} {RNA1310_139777} | |
45. | MligTC455_13775 | 5 | 0.1 | Mlig455_032965 | Neo: - Age: - |
0.973 | - | - | - | - | 0.973 | - | Mlig455_032965 {REF} {Length: 608} {NoTransDecoderORF} {RNA1310_139777} | |
46. | MligTC455_21967 | 46 | 0.96 | Mlig455_059500 | Neo: - Age: logFC(26M/2M)=-0.481 |
0.973 | - | - | - | - | 0.973 | - | Mlig455_059500 {REF} {Length: 3977} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=186.4]} {Mouse: ENSMUSG00000030873, Scnn1b, sodium channel, nonvoltage-gated 1 beta, [Score=53.5, Expect=6e-07]} {Smed: dd_Smed_v6_23771_0_1, dd_Smed_v6_23771_0_1, [RH, Score=382, Expect=8e-125]} {RNA1509_57431} {RNA1310_11500} {RNA815_5893} | |
47. | MligTC455_22024 | 15 | 0.32 | Mlig455_020103, Mlig455_069893 | Neo: Int S/G2/M Age: - |
0.973 | - | - | - | - | 0.973 | - | Mlig455_020103 {REF} {Length: 2186} {Pfam: gag-polyprotein putative aspartyl protease [PF13975.8, score=33.6]; Aspartyl protease [PF13650.8, score=27.9]; PNMA [PF14893.8, score=24.8]; Retroviral aspartyl protease [PF00077.22, score=22.0]} {RNA1509_39864} {RNA1310_9809} {RNA815_20192} Mlig455_069893 {REF} {Length: 2527} {Pfam: PNMA [PF14893.8, score=25.8]; Aspartyl protease [PF13650.8, score=19.9]; gag-polyprotein putative aspartyl protease [PF13975.8, score=19.4]} {RNA1509_38146} {RNA1310_9809} {RNA815_20192} |
|
48. | MligTC455_08381 | 23 | 0.47 | Mlig455_002943 | Neo: - Age: - Region-enriched R2: 6.789/0.00727 |
0.972 | - | - | - | - | 0.972 | - | Mlig455_002943 {REF} {Length: 944} {NoTransDecoderORF} {RNA1310_97351} {RNA815_52261} | |
49. | MligTC455_12841 | 12 | 0.25 | Mlig455_068006 | Neo: - |
0.972 | - | - | - | - | 0.972 | - | Mlig455_068006 {REF} {Length: 1150} {Pfam: Immunoglobulin I-set domain [PF07679.18, score=55.2]; Immunoglobulin domain [PF13927.8, score=36.7]; Immunoglobulin V-set domain [PF07686.19, score=28.0]; Immunoglobulin domain [PF13895.8, score=23.4]; Immunoglobulin domain [PF00047.27, score=20.3]} {Mouse: ENSMUSG00000061462, Obscn, obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF, [Score=48.1, Expect=1e-05]} {Dmel: FBgn0086906, sls, sallimus, [Score=54.3, Expect=1e-07]} {Celegans: WBGene00006759, unc-22, Twitchin, [Score=48.5, Expect=7e-06]} {Smed: dd_Smed_v6_2544_0_1, dd_Smed_v6_2544_0_1, [Score=82.8, Expect=6e-17]} {RNA1509_30594} {RNA1310_45, RNA1509_30594} {RNA1509_30594, RNA815_17} | |
50. | MligTC455_14933 | 10 | 0.2 | Mlig455_042268 | Neo: - Age: - |
0.972 | - | - | - | - | 0.972 | - | Mlig455_042268 {REF} {Length: 1019} {Smed: dd_Smed_v6_91651_0_1, dd_Smed_v6_91651_0_1, [Score=45.8, Expect=9e-07]} {RNA1509_48973} {RNA1310_22428.1} {RNA815_17155.1} | |
51. | MligTC455_26607 | 9 | 0.18 | Mlig455_015056 | Neo: - Age: - |
ANK1 | 0.972 | - | - | - | - | 0.972 | - | Mlig455_015056 {REF} {Length: 4136} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=354.3]; Ankyrin repeats (many copies) [PF13637.8, score=231.2]; Ankyrin repeat [PF00023.32, score=227.6]; Ankyrin repeat [PF13606.8, score=212.8]; Ankyrin repeats (many copies) [PF13857.8, score=192.8]; Mab-21 protein [PF03281.16, score=43.9]} {Human: ENSG00000029534, ANK1, ankyrin 1, [Score=253, Expect=7e-68]; ENSG00000145362, ANK2, ankyrin 2, [Score=245, Expect=2e-65]; ENSG00000151150, ANK3, ankyrin 3, [Score=243, Expect=2e-64]} {Mouse: ENSMUSG00000031543, Ank1, ankyrin 1, erythroid, [Score=241, Expect=2e-64]; ENSMUSG00000032826, Ank2, ankyrin 2, brain, [Score=238, Expect=4e-63]; ENSMUSG00000069601, Ank3, ankyrin 3, epithelial, [Score=236, Expect=2e-62]} {Dmel: FBgn0261788, Ank2, Ankyrin 2, [Score=242, Expect=1e-64]} {Celegans: WBGene00006780, unc-44, AO66 ankyrin, [Score=229, Expect=1e-60]} {Smed: dd_Smed_v6_2072_0_26, dd_Smed_v6_2072_0_26, [Score=224, Expect=3e-59]} {RNA1509_33337} {RNA1310_2213.1, RNA1509_33337} {RNA1509_33337, RNA815_649.1} |
52. | MligTC455_54689 | 3 | 0.07 | Mlig455_026467 | Neo: - Age: - |
0.971 | - | - | - | - | 0.971 | - | Mlig455_026467 {REF} {Length: 232} {NoTransDecoderORF} | |
53. | MligTC455_38054 | 15 | 0.31 | Mlig455_068611 | Neo: - Age: - |
0.97 | - | - | - | 0.970 | - | - | Mlig455_068611 {REF} {Length: 2344} {Pfam: Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=32.0]; 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=25.4]} {Smed: dd_Smed_v6_20444_0_1, dd_Smed_v6_20444_0_1, [Score=55.5, Expect=2e-08]} {RNA1310_51734} {RNA815_18074} | |
54. | MligTC455_45161 | 29 | 0.6 | Mlig455_027613 | Neo: Irradiation Age: - |
WSCD2 | 0.968 | - | - | - | 0.968 | - | - | Mlig455_027613 {REF} {Length: 1427} {Pfam: WSC domain [PF01822.21, score=56.9]; PAN domain [PF00024.28, score=21.6]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=54.3, Expect=4e-08]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=56.6, Expect=4e-09]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=61.2, Expect=8e-11]} {Celegans: WBGene00005024, sqv-6, Xylosyltransferase sqv-6, [Score=52.8, Expect=4e-08]} {RNA1509_29094} {RNA1310_36326} {RNA815_27950.1} |
55. | MligTC455_00899 | 7 | 0.15 | Mlig455_007785 | Neo: - Age: - |
0.967 | - | - | - | - | 0.967 | - | Mlig455_007785 {REF} {Length: 337} {NoTransDecoderORF} | |
56. | MligTC455_16858 | 26 | 0.53 | Mlig455_041709 | Neo: - Age: - |
0.967 | - | - | - | 0.967 | - | - | Mlig455_041709 {REF} {Length: 996} {NoTransDecoderORF} {RNA1310_81082} | |
57. | MligTC455_09356 | 14 | 0.29 | Mlig455_049750 | Neo: - Age: - Regeneration-upregulated R2: 5.695 Regeneration-enriched R2: 5.695 |
0.966 | - | - | - | - | 0.966 | - | Mlig455_049750 {REF} {Length: 377} {RNA1310_75863} | |
58. | MligTC455_13043 | 7 | 0.15 | Mlig455_069631 | Neo: - Age: - |
KREMEN1 | 0.966 | - | - | - | - | 0.966 | - | Mlig455_069631 {REF} {Length: 847} {Pfam: WSC domain [PF01822.21, score=51.4]; PAN domain [PF00024.28, score=26.6]; MANEC domain [PF07502.16, score=19.0]} {Human: ENSG00000183762, KREMEN1, kringle containing transmembrane protein 1, [Score=56.6, Expect=7e-09]} {Mouse: ENSMUSG00000020393, Kremen1, kringle containing transmembrane protein 1, [Score=59.3, Expect=6e-10]} {RNA1509_46267} {RNA1310_43993} {RNA815_32275.1} |
59. | MligTC455_16308 | 8 | 0.16 | Mlig455_039488 | Neo: - Age: - |
0.966 | - | - | - | - | 0.966 | - | Mlig455_039488 {REF} {Length: 2405} {NoTransDecoderORF} {RNA1509_44743} {RNA1310_27324} {RNA815_16253.2} | |
60. | MligTC455_41295 | 203 | 4.23 | Mlig455_007836 | Neo: - |
0.965 | - | - | - | 0.965 | - | - | Mlig455_007836 {REF} {Length: 2189} {RNA1509_59262} {RNA1310_31928, RNA1509_59262} {RNA1509_59262, RNA815_32415} | |
61. | MligTC455_55680 | 10 | 0.21 | Mlig455_008508 | Neo: - Age: - |
0.963 | - | - | - | - | 0.963 | - | Mlig455_008508 {REF} {Length: 462} {NoTransDecoderORF} | |
62. | MligTC455_10719 | 61 | 1.26 | Mlig455_041088 | Neo: - Age: - |
0.961 | - | - | - | 0.961 | - | - | Mlig455_041088 {REF} {Length: 338} {NoTransDecoderORF} {RNA1310_18998} | |
63. | MligTC455_13433 | 11 | 0.22 | Mlig455_025860 | Neo: - Age: - Region-enriched R2: 6.296/0.01497 |
0.961 | - | - | - | - | 0.961 | - | Mlig455_025860 {REF} {Length: 1640} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=35.7]} {RNA1310_51631} {RNA815_34338} | |
64. | MligTC455_14869 | 56 | 1.17 | Mlig455_041087 | Neo: - Age: - |
0.961 | - | - | - | 0.961 | - | - | Mlig455_041087 {REF} {Length: 1408} {RNA1310_35281} {RNA815_59011} | |
65. | MligTC455_10937 | 8 | 0.17 | Mlig455_019830 | Neo: - Age: Up-Up-Down |
ECE1 | 0.96 | - | - | - | - | 0.960 | - | Mlig455_019830 {REF} {Length: 2770} {Pfam: Peptidase family M13 [PF05649.15, score=49.8]; Peptidase family M13 [PF01431.23, score=28.5]} {Human: ENSG00000117298, ECE1, endothelin converting enzyme 1, [Score=72.8, Expect=2e-12]} {Mouse: ENSMUSG00000057530, Ece1, endothelin converting enzyme 1, [Score=72.4, Expect=1e-12]} {Dmel: FBgn0038818, Nep4, Neprilysin 4, [Score=71.2, Expect=3e-12]} {Celegans: WBGene00013926, nep-1, Neprilysin-1, [Score=68.9, Expect=8e-12]} {Smed: dd_Smed_v6_8276_0_1, dd_Smed_v6_8276_0_1, [Score=74.7, Expect=1e-13]} {RNA1509_38290} {RNA1310_10150} {RNA815_14976} |
66. | MligTC455_32832 | 57 | 1.19 | Mlig455_011184, Mlig455_011216, Mlig455_024755 | Neo: - Age: - |
0.96 | - | - | 0.960 | - | - | - | Mlig455_011184 {REF} {Length: 466} {NoTransDecoderORF} Mlig455_011216 {REF} {Length: 466} {NoTransDecoderORF} Mlig455_024755 {REF} {Length: 451} {NoTransDecoderORF} |
|
67. | MligTC455_08407 | 22 | 0.46 | Mlig455_043162 | Neo: - Age: - |
0.959 | - | - | 0.959 | - | - | - | Mlig455_043162 {REF} {Length: 1257} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=20.7]} {RNA1310_58288} {RNA815_55196} | |
68. | MligTC455_14860 | 14 | 0.3 | Mlig455_033599 | Neo: - Age: - |
0.958 | - | - | 0.958 | - | - | - | Mlig455_033599 {REF} {Length: 1075} {NoTransDecoderORF} {RNA1509_32111} {RNA1310_130308} {RNA815_53107.2} | |
69. | MligTC455_34488 | 72 | 1.5 | Mlig455_051688 | Neo: - Age: - |
DAG1 | 0.958 | - | - | - | - | 0.958 | - | Mlig455_051688 {REF} {Length: 4571} {TRANSSPLICED} {Pfam: Dystroglycan (Dystrophin-associated glycoprotein 1) [PF05454.13, score=47.3]; Alpha-Dystroglycan N-terminal domain 2 [PF18424.3, score=31.6]} {Human: ENSG00000173402, DAG1, dystroglycan 1, [RH, Score=61.2, Expect=1e-08]} {Mouse: ENSMUSG00000039952, Dag1, dystroglycan 1, [RH, Score=63.5, Expect=2e-09]} {Smed: dd_Smed_v6_11814_0_1, dd_Smed_v6_11814_0_1, [RH, Score=82.8, Expect=8e-16]} {RNA1509_57075} {RNA1310_1596.1, RNA1509_57075} {RNA1509_57075, RNA815_7113} |
70. | MligTC455_45774 | 17 | 0.35 | Mlig455_063164 | Neo: - Age: - |
0.957 | - | - | - | - | 0.957 | - | Mlig455_063164 {REF} {Length: 623} {NoTransDecoderORF} {RNA1509_27637} {RNA1310_5757} {RNA815_34558} | |
71. | MligTC455_37096 | 119 | 2.49 | Mlig455_050902 | Neo: - Age: - Region-enriched R6: 4.558/0.00557 |
PXDN | 0.956 | 0.956 | - | - | - | - | - | Mlig455_050902 {REF} {Length: 3987} {Pfam: Animal haem peroxidase [PF03098.17, score=504.8]; Immunoglobulin domain [PF13927.8, score=48.3]; Immunoglobulin I-set domain [PF07679.18, score=46.6]; Immunoglobulin domain [PF00047.27, score=29.7]; Immunoglobulin domain [PF13895.8, score=20.9]} {Human: ENSG00000130508, PXDN, peroxidasin, [Score=452, Expect=3e-139]} {Mouse: ENSMUSG00000020674, Pxdn, peroxidasin, [Score=446, Expect=4e-138]} {Dmel: FBgn0011828, Pxn, Peroxidasin, [Score=424, Expect=6e-129]} {Celegans: WBGene00004256, pxn-1, Peroxidasin homolog, [Score=403, Expect=8e-123]} {Smed: dd_Smed_v6_3603_0_1, dd_Smed_v6_3603_0_1, [Score=499, Expect=7e-160]} {RNA1509_8453} {RNA1310_4027} {RNA815_967.1} |
72. | MligTC455_53595 | 20 | 0.42 | Mlig455_067432 | Neo: - Age: - |
SLC24A2 | 0.955 | - | - | - | - | 0.955 | - | Mlig455_067432 {REF} {Length: 4224} {Pfam: Sodium/calcium exchanger protein [PF01699.26, score=186.7]} {Human: ENSG00000155886, SLC24A2, solute carrier family 24 member 2, [RH, Score=498, Expect=4e-168]} {Mouse: ENSMUSG00000037996, Slc24a2, solute carrier family 24 (sodium/potassium/calcium exchanger), member 2, [RH, Score=502, Expect=2e-169]} {Dmel: FBgn0028704, Nckx30C, [RH, Score=499, Expect=2e-166]} {Celegans: WBGene00003569, ncx-4, Na/Ca eXchangers, [Score=223, Expect=3e-64]} {Smed: dd_Smed_v6_5868_0_4, dd_Smed_v6_5868_0_4, [Score=184, Expect=9e-51]} {RNA1509_26587} {RNA1310_76563} {RNA815_21902.1} |
73. | MligTC455_05815 | 11 | 0.23 | Mlig455_045011 | Neo: - Age: - |
0.954 | - | - | - | - | 0.954 | - | Mlig455_045011 {REF} {Length: 572} {NoTransDecoderORF} {RNA1310_133647} | |
74. | MligTC455_11769 | 31 | 0.65 | Mlig455_037221 | Neo: - Age: - Regeneration-enriched R5: 6.907 |
LRRC74A | 0.954 | - | - | - | - | 0.954 | - | Mlig455_037221 {REF} {Length: 2742} {Pfam: Leucine Rich repeat [PF13516.8, score=28.7]; Leucine Rich Repeat [PF00560.35, score=21.6]} {Human: ENSG00000100565, LRRC74A, leucine rich repeat containing 74A, [Score=70.5, Expect=1e-12]} {Mouse: ENSMUSG00000059114, Lrrc74a, leucine rich repeat containing 74A, [Score=68.9, Expect=2e-12]} {Smed: dd_Smed_v6_14506_0_1, dd_Smed_v6_14506_0_1, [Score=72.0, Expect=1e-13]} {RNA1509_32489} {RNA1310_22966.1} {RNA815_15428} |
75. | MligTC455_29859 | 11 | 0.22 | Mlig455_011021 | Neo: - Age: - |
ITPR1 | 0.954 | - | - | - | - | 0.954 | - | Mlig455_011021 {REF} {Length: 2073} {Pfam: Ion transport protein [PF00520.33, score=19.8]} {Human: ENSG00000150995, ITPR1, inositol 1,4,5-trisphosphate receptor type 1, [Score=153, Expect=2e-38]} {Mouse: ENSMUSG00000030102, Itpr1, inositol 1,4,5-trisphosphate receptor 1, [Score=154, Expect=1e-38]} {Dmel: FBgn0010051, Itp-r83A, Inositol 1,4,5,-tris-phosphate receptor, [Score=138, Expect=1e-33]} {Celegans: WBGene00002173, itr-1, Inositol 1,4,5-trisphosphate receptor itr-1, [Score=136, Expect=3e-33]} {Smed: dd_Smed_v6_3814_1_2, dd_Smed_v6_3814_1_2, [Score=551, Expect=0.0]} {RNA1509_25537} {RNA1310_434.1} {RNA815_101} |
76. | MligTC455_23371 | 101 | 2.11 | Mlig455_006907 | Neo: - Age: Down-Up-Down Region-enriched R8: 3.403/0.01276 |
FSTL1 | 0.953 | - | - | - | 0.953 | - | - | Mlig455_006907 {REF} {Length: 3700} {Pfam: Immunoglobulin I-set domain [PF07679.18, score=60.0]; Immunoglobulin domain [PF13927.8, score=59.2]; Kazal-type serine protease inhibitor domain [PF07648.17, score=42.0]; Immunoglobulin domain [PF13895.8, score=33.6]; Immunoglobulin domain [PF00047.27, score=32.3]; Kazal-type serine protease inhibitor domain [PF00050.23, score=28.7]; Immunoglobulin V-set domain [PF07686.19, score=27.7]} {Human: ENSG00000163430, FSTL1, follistatin like 1, [RH, Score=68.9, Expect=3e-13]} {Mouse: ENSMUSG00000022816, Fstl1, follistatin-like 1, [RH, Score=68.2, Expect=6e-12]} {Celegans: WBGene00004256, pxn-1, Peroxidasin homolog, [Score=51.2, Expect=3e-06]} {RNA1509_41764} {RNA1310_9313, RNA1509_41764} {RNA1509_41764, RNA815_25649} |
77. | MligTC455_07822 | 103 | 2.14 | Mlig455_009973 | Neo: - Age: - Region-enriched R6: 8.220/0.00000 |
0.952 | 0.952 | - | - | - | - | - | Mlig455_009973 {REF} {Length: 1584} {RNA1310_20970} {RNA815_31710} | |
78. | MligTC455_27078 | 22 | 0.46 | Mlig455_028337, Mlig455_066176 | Neo: - Age: - |
0.951 | - | - | 0.951 | - | - | - | Mlig455_028337 {REF} {Length: 887} {NoTransDecoderORF} {RNA1509_59553} {RNA1310_69307} {RNA815_55083} Mlig455_066176 {REF} {Length: 883} {NoTransDecoderORF} {RNA1509_59553} {RNA1310_69307} {RNA815_55083} |
|
79. | MligTC455_23006 | 48 | 1 | Mlig455_001776 | Neo: - Age: logFC(26M/2M)=-0.676 |
0.95 | - | - | - | - | 0.950 | - | Mlig455_001776 {REF} {Length: 2604} {RNA1310_41105} {RNA815_50956} | |
80. | MligTC455_33913 | 32 | 0.66 | Mlig455_047326 | Neo: - Age: - |
SPON1 | 0.95 | - | - | 0.950 | - | - | - | Mlig455_047326 {REF} {Length: 2405} {Pfam: Spondin_N [PF06468.15, score=98.6]} {Human: ENSG00000262655, SPON1, spondin 1, [Score=117, Expect=1e-27]} {Mouse: ENSMUSG00000038156, Spon1, spondin 1, (f-spondin) extracellular matrix protein, [Score=115, Expect=4e-27]} {Dmel: FBgn0033710, CG17739, [Score=105, Expect=3e-24]} {Celegans: WBGene00006893, spon-1, SPONdin (Extracellular matrix glycoprotein) family, [Score=83.6, Expect=5e-17]} {Smed: dd_Smed_v6_2400_0_1, dd_Smed_v6_2400_0_1, [Score=83.6, Expect=4e-17]} {RNA1509_30850} {RNA1310_29306} {RNA815_50316} |
81. | MligTC455_46721 | 8 | 0.16 | Mlig455_053871 | Neo: - Age: - |
NPR1 | 0.95 | - | - | - | - | 0.950 | - | Mlig455_053871 {REF} {Length: 2774} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=100.4]; Nitrate and nitrite sensing [PF08376.12, score=82.7]} {Human: ENSG00000169418, NPR1, natriuretic peptide receptor 1, [Score=156, Expect=5e-39]; ENSG00000159899, NPR2, natriuretic peptide receptor 2, [Score=152, Expect=7e-38]} {Mouse: ENSMUSG00000027931, Npr1, natriuretic peptide receptor 1, [Score=155, Expect=7e-39]; ENSMUSG00000028469, Npr2, natriuretic peptide receptor 2, [Score=152, Expect=9e-39]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [Score=151, Expect=1e-37]; ENSMUSG00000055523, Gucy2g, guanylate cyclase 2g, [Score=149, Expect=5e-37]} {Dmel: FBgn0053958, CG33958, [Score=212, Expect=2e-59]} {Celegans: WBGene00001547, gcy-22, Receptor-type guanylate cyclase gcy-22, [Score=154, Expect=9e-39]} {Smed: dd_Smed_v6_9453_0_1, dd_Smed_v6_9453_0_1, [Score=159, Expect=2e-40]} {RNA1310_55195} |